UNSPSC 85503219: Restriction of left external carotid artery with bioactive intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of left external carotid artery with bioactive intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03VN4BZ

UNSPSC 85503219, Restriction of left external carotid artery with bioactive intraluminal device, percutaneous endoscopic approach, is a Commodity code that shows minimal relevance to recent state and local procurement activity. The code describes a specific surgical procedure involving vascular intervention with an implantable device—a narrow clinical service line. Recent opportunities tagged under this code, however, do not reflect the actual scope of work being solicited; instead, they span occupational medical surveillance, pharmacy benefit management, disability medical evaluations, surgical benefit carve-out programs, and temporary health professional staffing—none of which align with carotid artery intervention procedures.

The mismatch between the code's nominal scope and the actual buying patterns in the recent-opportunities block indicates that state and local procurement systems are applying this code inconsistently or that the code was assigned in error across multiple solicitations. The City of Phoenix Retirement Office (independent medical evaluations), the Washington State Department of Transportation (occupational medical surveillance), Collier County (pharmacy benefit management), the City of Long Beach (surgical benefit programs), and the County of Santa Clara Health System (temporary staffing pools) represent diverse issuing bodies across Arizona, Washington, Florida, California, and Texas, yet none are procuring carotid artery procedures. No recent opportunities reflect the clinical device or vascular surgical intervention the code is designed to capture, and no evidence supports active state or local procurement demand for this specific commodity in the current market.